FIELD: chemistry.
SUBSTANCE: invention relates to pharmacological chemistry, specifically to use of lithium ascorbate with formula LiC6H7O6 as an agent possessing antiarrhythmic action.
EFFECT: wider range of products with antiarrhythmic action.
1 cl, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
CARDIOPROTECTIVE AND ANTIARRHYTHMIC MEDICINE | 2022 |
|
RU2783444C1 |
AGENT FOR INCREASING RESISTANCE OF HEART TO ARRYTHMOGENIC ACTION OF ISCHAEMIA AND REPERFUSION | 2014 |
|
RU2587783C1 |
ANTI-ARRHYTHMIC AGENT | 2004 |
|
RU2260442C1 |
ANTI-ARRHYTHMIC AGENT | 2003 |
|
RU2235553C1 |
ANTI-ARRHYTHMIC AGENT | 2005 |
|
RU2320342C2 |
METHOD FOR SIMULATION OF INCREASED STABILITY OF RAT MYOCARDIUM TO ISCHEMIC-REPERFUSION DAMAGE | 2016 |
|
RU2623727C1 |
ANTI-ARRHYTHMIC AGENT | 2001 |
|
RU2195275C1 |
AGENT ELICITING ANTI-ISCHEMIC, HYPOTENSIVE, ANTI- -ARRHYTHMIC AND NOOTROPIC ACTIVITY | 2002 |
|
RU2216322C1 |
COMPOSITION OF AMINO ACIDS WITH TRACE ELEMENTS ELICITING ANTIARRHYTHMIC ACTIVITY | 1999 |
|
RU2173553C2 |
2-MERCAPTOBENZIMIDAZOLE DERIVATIVES SHOWING ANTI-ISCHEMIC, ANTI-ARRHYTHMIC AND ANTIFIBRILLATORY ACTIVITY | 1995 |
|
RU2136667C1 |
Authors
Dates
2019-09-16—Published
2019-05-16—Filed